These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38654456)

  • 1. COVID-19 Vaccination-Related Myocarditis: What We Learned From Our Experience and What We Need to Do in The Future.
    Park JH; Kim KH
    Korean Circ J; 2024 Jun; 54(6):295-310. PubMed ID: 38654456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccination-related myocarditis: a Korean nationwide study.
    Cho JY; Kim KH; Lee N; Cho SH; Kim SY; Kim EK; Park JH; Choi EY; Choi JO; Park H; Kim HY; Yoon HJ; Ahn Y; Jeong MH; Cho JG
    Eur Heart J; 2023 Jun; 44(24):2234-2243. PubMed ID: 37264895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of COVID-19 vaccine-induced myocarditis.
    Rose J; Hulscher N; McCullough PA
    Ther Adv Drug Saf; 2024; 15():20420986241226566. PubMed ID: 38293564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination and myocarditis: A review of current literature.
    Dhaduk K; Khosla J; Hussain M; Mangaroliya V; Chauhan S; Ashish K; Gupta R; Pal S
    World J Virol; 2022 Jul; 11(4):170-175. PubMed ID: 36159608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.
    Mahasing C; Doungngern P; Jaipong R; Nonmuti P; Chimmanee J; Wongsawat J; Boonyasirinant T; Wanlapakorn C; Leelapatana P; Yingchoncharoen T; Ngarmukos T; Chokephaibulkit K; Srimahachota S
    Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings.
    Cadegiani FA
    Cureus; 2022 Aug; 14(8):e27883. PubMed ID: 35971401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    Stowe J; Miller E; Andrews N; Whitaker HJ
    PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis.
    Chou OHI; Mui J; Chung CT; Radford D; Ranjithkumar S; Evbayekha E; Nam R; Pay L; Satti DI; Garcia-Zamora S; Bazoukis G; Çinier G; Lee S; Vassiliou VS; Liu T; Tse G; Wong ICK; ; Chou OHI; Liu T; Tse G
    Clin Res Cardiol; 2022 Oct; 111(10):1161-1173. PubMed ID: 35906423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction.
    Ameratunga R; Woon ST; Sheppard MN; Garland J; Ondruschka B; Wong CX; Stewart RAH; Tatley M; Stables SR; Tse RD
    J Clin Immunol; 2022 Apr; 42(3):441-447. PubMed ID: 34978002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022.
    Sim JY; Kim SY; Kim EK
    Osong Public Health Res Perspect; 2023 Apr; 14(2):76-88. PubMed ID: 37183328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations.
    Power JR; Keyt LK; Adler ED
    Expert Rev Cardiovasc Ther; 2022 Apr; 20(4):241-251. PubMed ID: 35414326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study.
    Kracalik I; Oster ME; Broder KR; Cortese MM; Glover M; Shields K; Creech CB; Romanson B; Novosad S; Soslow J; Walter EB; Marquez P; Dendy JM; Woo J; Valderrama AL; Ramirez-Cardenas A; Assefa A; Campbell MJ; Su JR; Magill SS; Shay DK; Shimabukuro TT; Basavaraju SV;
    Lancet Child Adolesc Health; 2022 Nov; 6(11):788-798. PubMed ID: 36152650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.
    Patone M; Mei XW; Handunnetthi L; Dixon S; Zaccardi F; Shankar-Hari M; Watkinson P; Khunti K; Harnden A; Coupland CAC; Channon KM; Mills NL; Sheikh A; Hippisley-Cox J
    Circulation; 2022 Sep; 146(10):743-754. PubMed ID: 35993236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.
    Eslait-Olaciregui S; Llinás-Caballero K; Patiño-Manjarrés D; Urbina-Ariza T; Cediel-Becerra JF; Domínguez-Domínguez CA
    Ther Adv Drug Saf; 2023; 14():20420986231165674. PubMed ID: 37223456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Occurrence of Immune-Mediated Thrombocytopenia and Myocarditis After mRNA-1273 COVID-19 Vaccination: A Case Report.
    Bae DH; Kim M; Lee DI; Lee JH; Kim S; Lee SY; Bae JW; Hwang KK; Kim DW; Cho MC
    J Korean Med Sci; 2022 May; 37(21):e169. PubMed ID: 35638196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epidemiology of COVID-19 Vaccine-Induced Myocarditis.
    Costa C; Moniati F
    Adv Med; 2024; 2024():4470326. PubMed ID: 38681683
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.